Artificial intelligence continues to reshape biotech research and clinical applications, with breakthroughs including the development of AI models validated in diverse populations and novel AI-driven bioinformatics platforms. The Sybil AI lung cancer risk model was shown effective in a predominantly Black cohort, addressing health disparities. Additionally, innovative graph-based ODE-VAEs improve clustering in single-cell data analyses. Startups like Hello Patient raised $22.5 million to expand conversational AI health solutions, emphasizing AI’s growing role in personalized medicine and diagnostics.